Skip to content
Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
Menu
  • Pα+
Search
Join Pα+
  • Sign in
Menu
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Read more about the article Silo Pharma Announces Positive Results from IND-Enabling Study of SP-26 for Fibromyalgia

Silo Pharma Announces Positive Results from IND-Enabling Study of SP-26 for Fibromyalgia

  • Post published:March 15, 2023
  • Post category:Press Release
Read more about the article FILAMENT HEALTH ANNOUNCES FDA APPROVAL OF PHASE II CLINICAL TRIAL STUDYING PSILOCYBIN FOR METHAMPHETAMINE USE DISORDER

FILAMENT HEALTH ANNOUNCES FDA APPROVAL OF PHASE II CLINICAL TRIAL STUDYING PSILOCYBIN FOR METHAMPHETAMINE USE DISORDER

  • Post published:March 15, 2023
  • Post category:Press Release
Read more about the article CORRECTION — BetterLife Closes $1,857,143 of Private Placement

CORRECTION — BetterLife Closes $1,857,143 of Private Placement

  • Post published:March 14, 2023
  • Post category:Press Release
Read more about the article Mindset Pharma To Defend Against Lawsuit Filed By Reunion Neurosciences

Mindset Pharma To Defend Against Lawsuit Filed By Reunion Neurosciences

  • Post published:March 14, 2023
  • Post category:Press Release
Read more about the article Clearmind Medicine Appoints Professor Henry R. Kranzler, M.D., to Scientific Advisory Board

Clearmind Medicine Appoints Professor Henry R. Kranzler, M.D., to Scientific Advisory Board

  • Post published:March 14, 2023
  • Post category:Press Release
Read more about the article BetterLife Closes $1,857,143 of Private Placement

BetterLife Closes $1,857,143 of Private Placement

  • Post published:March 14, 2023
  • Post category:Press Release
Read more about the article Reunion Neuroscience Files Lawsuit Against Mindset Pharma

Reunion Neuroscience Files Lawsuit Against Mindset Pharma

  • Post published:March 13, 2023
  • Post category:Press Release
Read more about the article BetterLife Files Amended and Restated Offering Document for Offering of Units

BetterLife Files Amended and Restated Offering Document for Offering of Units

  • Post published:March 11, 2023
  • Post category:Press Release
Read more about the article Betterlife Publishes Promising Results from a Study Titled “A Non-Hallucinogenic LSD Analog With Therapeutic Potential For Mood Disorders”

Betterlife Publishes Promising Results from a Study Titled “A Non-Hallucinogenic LSD Analog With Therapeutic Potential For Mood Disorders”

  • Post published:March 9, 2023
  • Post category:Press Release
Read more about the article BetterLife Announces Pricing of Proposed Offering of Units

BetterLife Announces Pricing of Proposed Offering of Units

  • Post published:March 8, 2023
  • Post category:Press Release

End of content

No more pages to load

← Newer Posts
Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More